MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc. (INKT)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
10. 59
-0.48
-4.336%
$
52.76M Market Cap
- P/E Ratio
- Div Yield
9,312 Volume
-0.56 Eps
$ 11.07
Previous Close
Investors:
Analysts:
Add Transaction
Day Range
10.5 11.13
Year Range
8.48 19.61
Want to track INKT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

MiNK Therapeutics, Inc. (INKT) Statistics

Valuation metrics

Market Cap 52.76M
Enterprise value 45.62M
Trailing P/E (ttm) -3.91
Forward P/E -
PEG ratio 0.34
Price/Sales (ttm) -
Price/Book (mrq) -4.19
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.71

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 20.45K
Average volume (90 days) 28.07K

Price summary

52-Week low 8.48
52-Week high 19.61
Beta -
50-Day moving average 11.88
200-Day moving average 11.27

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 28 Jan 2025

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.2%
Return on equity 0.76%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.6
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.99
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.38%
Book value per share (mrq) -2.64

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -